Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-005792

Options or other derivatives

  • CHIEF COMMERCIAL OFFICER acquired 45,113 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Moat Ross CHIEF COMMERCIAL OFFICER 2023-04-01 Grant or award · Share Option +38,668 38,668 D
Moat Ross CHIEF COMMERCIAL OFFICER 2023-04-01 Grant or award · Restricted Share Unit +6,445 6,445 D
Loading xslF345X04/form4-04032023_040423.xml…